查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1882233

全球qPCR及dPCR儀器市場

qPCR and dPCR Instrumentation
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 573 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球qPCR和dPCR儀器市場預計到2030年將達到135億美元

全球qPCR和dPCR設備市場規模在2024年估計為81億美元，預計到2030年將達到135億美元，在分析期間（2024-2030年）內複合年成長率（CAGR）為9.0%。 qPCR設備是本報告分析的細分市場之一，預計其複合年成長率將達到8.4%，並在分析期結束時達到113億美元。 dPCR設備細分市場預計在分析期間將以11.9%的複合年成長率成長。

美國市場規模估計為25億美元，而中國市場預計將以11.6%的複合年成長率成長。

預計到2024年，美國qPCR和dPCR設備市場規模將達25億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到12億美元，2024年至2030年的複合年成長率（CAGR）為11.6%。其他值得關注的區域市場分析包括日本和加拿大，預計在分析期間內，這兩個國家的複合年成長率將分別達到7.4%和7.8%。在歐洲，德國的複合年成長率預計將達到約8.3%。

全球qPCR和dPCR設備市場—主要市場趨勢和促進因素概述

定量PCR (qPCR) 和數位PCR (dPCR) 儀器是分子生物學中用於精確定量核酸的重要工具，可應用於多種領域。 qPCR，也稱為即時PCR，可在PCR過程中即時測量DNA的積累，從而實現特定DNA序列的定量。由於其靈敏度高、特異性強且能夠提供定量數據，因此該技術被廣泛應用於診斷、基因表現分析和病原體檢測。另一方面，dPCR將樣本分成數千個獨立的反應，無需標準曲線即可提供絕對的DNA定量結果。此方法尤其適用於檢測低濃度標靶和分析複雜混合物，使其在臨床診斷、遺傳研究和環境檢測中具有極高的價值。

技術進步顯著提升了qPCR和dPCR儀器的性能和功能。現代qPCR系統配備了精密的聚合酵素連鎖反應熱迴圈儀、靈敏的光學檢測系統以及便於數據分析的軟體。這些儀器專為高通量檢測而設計，能夠同時分析多個樣本並縮短實驗時間。此外，多重技術的發展使得在單次反應中檢測多個標靶成為可能，從而提高了qPCR篩檢的效率和成本效益。 dPCR技術也取得了長足發展，微流體平台和液滴系統等創新技術提高了分餾精度和重複性。這些進步拓寬了dPCR的應用範圍，使其能夠更精確地定量分析罕見突變、拷貝數變異和病原體載量。

qPCR 和 dPCR 設備市場的成長受多種因素驅動。醫療保健領域對精準快速診斷工具的需求不斷成長是主要驅動力，尤其是 COVID-19 疫情凸顯了可靠核酸檢測的重要性。基因研究和個人化醫療的進步也推動了市場成長，qPCR 和 dPCR 在基因表現分析、突變檢測和生物標記發現方面發揮著至關重要的作用。包括開發更靈敏、更高通量的儀器在內的技術進步，吸引了許多研究人員和臨床醫生，他們希望藉此提升分析能力。此外，這些技術在農業、食品安全和環境監測等領域的應用不斷擴展，也促進了其普及。政府對基因組研究和公共衛生舉措的資助和投資也進一步推動了市場成長。這些因素，加上持續的創新以及自動化和數位化解決方案的整合，預計將在未來幾年推動 qPCR 和 dPCR 設備市場持續成長。

部分：

分類（qPCR、dPCR）、組成部分（試劑和耗材、設備、軟體和服務）、最終用途（醫院和診斷中心、研究實驗室和學術機構、製藥和生物技術公司、臨床研究機構、法醫學實驗室）

受訪公司範例

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Asuragen, Inc.
  • Analytik Jena AG
  • Biocartis NV
  • Biotecon Diagnostics GmbH
  • BioFire Diagnostics LLC
  • Alifax SpA
  • Anitoa Systems LLC
  • AB ANALITICA srl
  • Bio Molecular Systems

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，革新市場和競爭情報分析。

Market Glass, Inc. 並沒有查詢LLM 或產業專用的SLM 的典型方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括影片轉錄、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在地、製造地以及進出口（成品和OEM產品）情況，預測企業競爭地位的變化。這種複雜多變的市場現實會從多個方面影響競爭對手，包括增加銷貨成本、降低盈利和重組供應鏈，同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 亞太其他地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP-7856

Global qPCR and dPCR Instrumentation Market to Reach US$13.5 Billion by 2030

The global market for qPCR and dPCR Instrumentation estimated at US$8.1 Billion in the year 2024, is expected to reach US$13.5 Billion by 2030, growing at a CAGR of 9.0% over the analysis period 2024-2030. qPCR Instrumentation, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$11.3 Billion by the end of the analysis period. Growth in the dPCR Instrumentation segment is estimated at 11.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.5 Billion While China is Forecast to Grow at 11.6% CAGR

The qPCR and dPCR Instrumentation market in the U.S. is estimated at US$2.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 11.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.4% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Global qPCR and dPCR Instrumentation Market - Key Trends & Drivers Summarized

Quantitative PCR (qPCR) and digital PCR (dPCR) instrumentation are critical tools in molecular biology, enabling precise and accurate quantification of nucleic acids in various applications. qPCR, also known as real-time PCR, measures the accumulation of DNA during the PCR process in real-time, allowing for the quantification of specific DNA sequences. This technique is widely used in diagnostics, gene expression analysis, and pathogen detection due to its sensitivity, specificity, and ability to provide quantitative data. dPCR, on the other hand, partitions a sample into thousands of individual reactions, providing absolute quantification of DNA without the need for standard curves. This method is particularly advantageous for detecting low-abundance targets and analyzing complex mixtures, making it highly valuable in clinical diagnostics, genetic research, and environmental testing.

Technological advancements have significantly enhanced the performance and capabilities of qPCR and dPCR instruments. Modern qPCR systems feature advanced thermal cyclers, highly sensitive optical detection systems, and user-friendly software that streamline data analysis. These instruments are designed for high throughput, enabling simultaneous analysis of multiple samples and reducing the time required for experiments. Additionally, the development of multiplexing capabilities allows for the detection of several targets in a single reaction, increasing the efficiency and cost-effectiveness of qPCR assays. dPCR technology has also evolved, with innovations such as microfluidic platforms and droplet-based systems that enhance partitioning accuracy and reproducibility. These advancements have expanded the applications of dPCR, enabling more precise quantification of rare mutations, copy number variations, and pathogen loads.

The growth in the qPCR and dPCR instrumentation market is driven by several factors. The increasing demand for accurate and rapid diagnostic tools in the healthcare sector is a primary driver, particularly in the wake of the COVID-19 pandemic, which underscored the need for reliable nucleic acid testing. The rise in genetic research and personalized medicine is also propelling market growth, as qPCR and dPCR are essential for gene expression analysis, mutation detection, and biomarker discovery. Technological advancements, including the development of more sensitive and high-throughput instruments, are attracting researchers and clinicians seeking to improve their analytical capabilities. Furthermore, the expansion of applications in agriculture, food safety, and environmental monitoring is boosting the adoption of these technologies. Government funding and investments in genomic research and public health initiatives are further supporting market growth. These factors, combined with continuous innovation and the integration of automated and digital solutions, are expected to drive sustained growth in the qPCR and dPCR instrumentation market in the coming years.

SCOPE OF STUDY:

The report analyzes the qPCR and dPCR Instrumentation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Classification (qPCR, dPCR); Component (Reagents & Consumables, Instruments, Software & Services); End-Use (Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations, Forensic Laboratories)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 74 Featured) -

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Asuragen, Inc.
  • Analytik Jena AG
  • Biocartis NV
  • Biotecon Diagnostics GmbH
  • BioFire Diagnostics LLC
  • Alifax SpA
  • Anitoa Systems LLC
  • AB ANALITICA s.r.l.
  • Bio Molecular Systems

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Polymerase Chain Reaction (PCR): An Integral Part of Gene Amplification & Quantification
    • Global Economic Update
    • qPCR and dPCR Instrumentation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Real-Time PCR and Digital PCR: Scope and Definition
    • Real-Time PCR or Quantitative PCR (qPCR)
    • qPCR Instrumentation
    • Disadvantages
    • Advantages of qPCR
    • End-Use Applications of qPCR
    • Digital PCR (dPCR)
    • Working Principle
    • Applications of dPCR
    • Advantages of dPCR
    • qPCR Remains the Mainstay Technology
    • Digital PCR to Experience Strong Growth
    • High Installation Cost Remains a Roadblock to Widespread Adoption of dPCR
    • Developing Countries Drive Growth Opportunities
    • Competition
    • Competitive Factors
    • Accelerated Commercialization of Products
    • Manufacturers Step-Up Online Exposure
    • Targeted Expansion of Distribution Reach and Global Footprint
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Striking the Right Balance between qPCR and dPCR in Research Laboratories
    • qPCR: A Suitable Tool for Gene Expression and Validation
    • Digital PCR Takes Quantification of Nucleic Acids to the Next Level
    • dPCR: A Valuable Tool in Virology Research
    • Increasing Incidence and Prevalence of Cancer: A Grim Reality Driving Demand for qPCR and dPCR
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • dPCR for Analyzing Hematologic Malignancies
    • dPCR for Liquid Biopsies
    • Progress in Molecular Diagnostics Spur Demand for the Gene Amplification Technologies
    • Prospects for Predictive Genetic Diagnostics and Testing Grow Brighter
    • Global Genetic Testing Market in US$ Billion: 2020 and 2027
    • Rise in Infectious Diseases Drives Opportunities for Biochips
    • Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
    • Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
    • Innovations in Instrumentation Expand Functionality and Drive Adoption
    • Advancements in Probe Technology Enhance qPCR Sensitivity
    • qPCR Market to Witness Increasing Affinity for Automated and Robotic Equipment
    • Lab on Chip/Microfluidic Real-time-PCR
    • Synoptic Review of Quantitative PCR Technical Advancements in the Recent Years
    • ddPCR: The More Advanced Digital Approach to dPCR
    • ddPCR Gains Traction in Cancer Diagnosis
    • Monitoring Disease Progression in HIV Studies
    • Analysis of Genetically Modified Organisms in Edible Products
    • RT-ddPCR Techniques Applied for Quantitating RNA Viruses in Water Samples
    • Technology Advancements Aid in Overcoming Barriers
    • Alternate Technologies Pose Threat to Growth of PCR Market
    • Improving Healthcare Expenditure to Drive Demand for qPCR and dPCR-based Tests
    • PCR in Forensic and Paternity Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for qPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for qPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for qPCR by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for dPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for dPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for dPCR by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Research Laboratories & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Research Laboratories & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Research Laboratories & Academic Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Clinical Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Clinical Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Clinical Research Organizations by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Forensic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Forensic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Forensic Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 31: World qPCR and dPCR Instrumentation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for qPCR and dPCR Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • JAPAN
    • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • CHINA
    • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • EUROPE
    • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for qPCR and dPCR Instrumentation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • GERMANY
    • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • INDIA
    • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for qPCR and dPCR Instrumentation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for qPCR and dPCR Instrumentation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030
  • AFRICA
    • qPCR and dPCR Instrumentation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2015, 2025 & 2030

IV. COMPETITION